(S)-2-((tert-Butoxycarbonyl)amino)-3-((tert-butyldiphenylsilyl)oxy)propanoic acid, 96.0%, 250mg

[S(R)]-N-[(1S)-2-(Diphenylphosphino)-1-[2-(diphenylphosphino)phenyl]ethyl]]-2-methyl-N,2-dimethyl-2-propanesulfinamide, 95%, 1g

Tridecan-7-amine>97.0%(GC)5mL

{[4-(2-methylpropyl)phenyl]methyl}(prop-2-en-1-yl)amine hydrochloride, 95.0%, 10g

(1-isopropyl-4-piperidinylidene)acetic acid hydrate, 95.0%, 25g

(S)-3-Bromo-5-iodo-2-(1-methoxyethyl)pyridine, 98%, 1g

4-Chloro-2-(methylthio)thiazolo[5,4-c]pyridine, 95.0%, 250mg

7-Bromo-2-methyl-1,2,3,4-tetrahydroisoquinoline, 97%, 5g

2-Bromo-5-nitrobenzoic acid, 98%, 25g

(5-Methyl-4 H -[1,2,4]triazol-3-ylsulfanyl)-acetic acid, 95.0%, 100mg

MCC, 50mg

6-(3-Methoxyphenyl)-4-methyl-2-(2-morpholinoethyl)pyridazin-3(2H)-one hydrochloride, 98.0%, 250mg

2-Bromo-4-fluoro-5-methylpyridine, 95.0%, 250mg